Unknown NA INTERVENTIONAL 2-arm NCT05613491

Intranasal Insulin Improves Postoperative Neurocognitive Disorders in Elderly Patients

Intranasal Insulin Improves Postoperative Neurocognitive Disorders in Elderly Patients: a Multicenter, Randomized, Double-blind, Placebo-controlled Study

Sponsor: 521 Hospital of NORINCO Group

Conditions Postoperative Neurocognitive Disorders

Interventions Intranasal insulin Intranasal saline

Updated 4 times since 2022 Last updated: Nov 6, 2022 Started: Nov 7, 2022 Primary completion: Jul 31, 2023 Completion: Aug 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05613491, this NA trial focuses on Postoperative Neurocognitive Disorders and remains ongoing. Sponsored by 521 Hospital of NORINCO Group, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Dec 2024 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Dec 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Dec 2022 — Jul 2024 [monthly]

Recruiting NA

First recorded

Nov 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

521 Hospital of NORINCO Group
First Affiliated Hospital Xi'an Jiaotong University
LanZhou University
Second Hospital of Shanxi Medical University
Sichuan Provincial People's Hospital
Tang-Du Hospital
The First Affiliated Hospital of Zhengzhou University
Tongji Hospital

Data source: First Affiliated Hospital Xi'an Jiaotong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi'an, China